MedPage Today2h
FDA Approves Novel Treatment for UTIs
The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) ...
FiercePharma4h
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...
US FDA approves Iterum's treatment for urinary infection
The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat a type of urinary tract ...
Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...
Iterum Therapeutics Gets FDA Approval Of Orlynvah For Treatment Of Urinary Tract Infections
This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients, ...
Medscape23h
Diagnosis and Management of Candida of the Nipple and Breast
In addition to the physical examination, it is recommended that the breastfeeding mother have an examination by a lactation specialist or a practitioner knowledgeable about breastfeeding to ...